id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-P-0610-0003,FDA,FDA-2011-P-0610,"FDA/CDER Letter to Mayer Brown LLP, dated February 16, 2012",Other,Letter(s),2012-04-05T04:00:00Z,2012,4,2012-04-05T04:00:00Z,,2019-07-08T14:20:51Z,,0,0,0900006480fea041